ORA - Oxford University Research Archive

1 - 4 of 4

1

Journal article

Pexmetinib: a novel dual inhibitor of Tie-2 and p38 MAPK with efficacy in preclinical models of myelodysplastic syndromes and acute myeloid leukemia.

Bachegowda, L, Morrone, K, Winski, SL, et al.
2016-06-05

2

Conference

Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes

Sundaravel, S, Bhagat, TD, Schinke, C, et al.
2012-11-16

3

Conference

Aberrant Expression of DOCK4 Leads to Disruption of the F-Actin Skeleton and Altered Membrane Stability in MDS Erythroblasts and Mature Erythrocytes

Sundaravel, S, Bhagat, TD, Schinke, C, et al.
2012-11-16

4

Journal article

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.

Will, B, Zhou, L, Vogler, TO, et al.
2012-09-05

TO TOP